LediHep Tablets

LediHep Tablets Specification

Salt Composition
Ledipasvir 90 mg and Sofosbuvir 400 mg

Indication
Chronic Hepatitis C Virus (HCV) infection

Origin
India

Dosage Form
Tablet

Enzyme Types
LediHep Tablets

Feature
For oral administration; Prescription drug

Application
Antiviral Therapy

Physical Color/Texture
Yellow, film-coated tablets

Storage Instructions
Cool & Dry Place

Shelf Life
24 Months

Trade Name
LediHep

International Status
Export Quality, WHO GMP Certified

Prescription/Non Prescription
Prescription

Therapeutic Classification
Direct-Acting Antiviral (DAA)

Packaging Size
28 Tablets per bottle

Administration Route
Oral

LediHep Tablets Trade Information

Minimum Order Quantity
5000 Pieces

Supply Ability
100 Pieces Per Day

Delivery Time
3-4 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About LediHep Tablets

Ledihep Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection. Ledihep Tablet is a combination of two antiviral medicines Ledipasvir and Sofosbuvir. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time.

Mechanism of Action

LediHep combines Ledipasvir and Sofosbuvir, which work synergistically to inhibit the replication of the Hepatitis C Virus. As direct-acting antivirals, these components target specific enzymes essential for viral multiplication, leading to a marked reduction in viral load when taken as prescribed.

Administration and Dosage

LediHep Tablets are intended for oral administration under medical supervision. The usual regimen involves one tablet per day, with or without food, for a duration determined by the prescribing physician, based on the patient's condition and genotype of HCV infection.

Quality and Certification

Manufactured in compliance with international standards, LediHep is WHO GMP Certified and classified as export quality from India. This ensures the highest manufacturing and quality assurance protocols, providing reliability and safety for patients globally.

FAQ's of LediHep Tablets:

Q: How should LediHep Tablets be taken for optimal effectiveness?

A: LediHep Tablets should be taken orally, once daily, exactly as prescribed by your healthcare provider. It is important not to miss doses and to complete the prescribed course, as this maximizes the treatment's antiviral effectiveness.

Q: What is the main benefit of using LediHep for treating chronic Hepatitis C?

A: LediHep offers a high cure rate for chronic Hepatitis C infection due to its potent combination of Ledipasvir and Sofosbuvir. These direct-acting antivirals significantly decrease the viral load, improving liver health and overall treatment outcomes.

Q: When should LediHep Tablets be avoided or not used?

A: LediHep Tablets should not be used without a valid prescription, or in cases of known allergy to any of its ingredients. Always consult a specialist before starting, especially if you are pregnant, breastfeeding, or on other medications.

Q: Where should LediHep Tablets be stored to preserve their quality?

A: Store LediHep Tablets in a cool, dry place away from direct sunlight and moisture. Keeping the bottle tightly closed will help maintain their efficacy throughout their 24-month shelf life.

Q: What is the process for obtaining LediHep Tablets internationally?

A: LediHep is available through authorized exporters, suppliers, and traders in India and can be exported globally, thanks to its export quality status and WHO GMP certification. A medical prescription is required for purchase.

Q: What ingredients are included in LediHep Tablets?

A: LediHep Tablets contain the active substances Ledipasvir (90 mg) and Sofosbuvir (400 mg), along with pharmaceutical excipients to ensure stability and consistent drug delivery.

Tell us about your requirement